Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05229926 · ClinicalTrials.gov registry record

Implementation of CareCube Negative Pressure Isolation Units

A clinical trial of Infectious Disease, sponsored by Saint Luke's Health System.

Completed
Registry status
16
Enrollment target
1
Study location

NCT05229926 is a study of Infectious Disease that has completed, run by Saint Luke's Health System. The registered enrollment target is 16 participants, below the 7,024-participant average among 18 other Infectious Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05229926, a study of Infectious Disease, has completed, sponsored by Saint Luke's Health System.

COMPLETED
Registry status
16 participants
Enrollment target
1
Study location

Study Summary

Pilot study to provide a descriptive analysis of the real-world feasibility of using a CareCube for COVID-19 patients in a high-volume tertiary care hospital.

Conditions Studied

Interventions

  • DEVICE CareCube

Study Locations (1)

Missouri

  • Saint Luke's Hospital of Kansas City - Kansas City

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2021-03-27
Est. Completion 2021-03-27

Sponsor

Saint Luke's Health System

26 total trials

What the Registry Record Tells You About NCT05229926

The ClinicalTrials.gov registry entry for NCT05229926 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,024-participant average among 18 other Infectious Disease trials with a reported enrollment target (100% lower). The listed sponsor is Saint Luke's Health System, which has 26 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infectious Disease appearing as the primary indexed condition, and to 1 intervention - of which CareCube is the first listed.

NCT05229926 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT05229926 about?

NCT05229926 is a clinical study titled "Implementation of CareCube Negative Pressure Isolation Units". Pilot study to provide a descriptive analysis of the real-world feasibility of using a CareCube for COVID-19 patients in a high-volume tertiary care hospital.

What is the current status of trial NCT05229926?

This trial is currently completed. The enrollment target is 16 participants. The study started on 2021-03-27. Estimated completion is 2021-03-27.

What conditions does trial NCT05229926 study?

This clinical trial studies the following conditions: Infectious Disease.

What interventions are being tested in trial NCT05229926?

The interventions under investigation include: CareCube (DEVICE).

Who is sponsoring clinical trial NCT05229926?

This trial is sponsored by Saint Luke's Health System, which has 26 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05229926 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infectious Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.